Dr. Maha Katabi
Insider
Activist
First SEC filing: June 29, 2021 · Latest: Feb. 25, 2025
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 14, 2025 | VERA | A | 14,000 | · | · | 14,000 Direct | · | Acquired | (price as of 2026-10-06) |
| June 5, 2024 | JBIO | A | 12,500 | · | · | 12,500 Direct | · | Acquired | (price as of 2026-10-06) |
| May 15, 2024 | VERA | A | 14,000 | · | · | 14,000 Direct | · | Acquired | (price as of 2026-10-06) |
| March 25, 2024 | VERA | S | 340,000 | $40.50 | $13,770,000 | 2,793,987 Indirect | -10.85% | Disposed | -27.0% (price as of 2026-10-06) |
| March 22, 2024 | VERA | S | 413,450 | $40.51 | $16,748,860 | 3,133,987 Indirect | -11.65% | Disposed | -27.0% (price as of 2026-10-06) |
| March 21, 2024 | VERA | S | 13,718 | $46.18 | $633,497 | 3,547,437 Indirect | -0.39% | Disposed | -36.0% (price as of 2026-10-06) |
| March 21, 2024 | VERA | S | 12,617 | $45.52 | $574,326 | 3,561,155 Indirect | -0.35% | Disposed | -35.0% (price as of 2026-10-06) |
| March 21, 2024 | VERA | S | 21,918 | $44.00 | $964,392 | 3,573,772 Indirect | -0.61% | Disposed | -32.8% (price as of 2026-10-06) |
| March 21, 2024 | VERA | S | 32,756 | $43.00 | $1,408,508 | 3,595,690 Indirect | -0.90% | Disposed | -31.2% (price as of 2026-10-06) |
| Jan. 30, 2024 | VERA | P | 161,290 | $31.00 | $4,999,990 | 3,628,446 Indirect | +4.65% | Acquired | -4.6% (price as of 2026-10-06) |
| Jan. 2, 2024 | JBIO | A | 3,519 | $13.49 | $47,471 | 3,519 Direct | · | Acquired | -97.1% (price as of 2026-10-06) |
| June 6, 2023 | JBIO | A | 12,500 | · | · | 12,500 Direct | · | Acquired | (price as of 2026-10-06) |
| May 10, 2023 | VERA | A | 20,000 | · | · | 20,000 Direct | · | Acquired | (price as of 2026-10-06) |
| Jan. 3, 2023 | JBIO | A | 2,627 | $18.08 | $47,496 | 2,627 Direct | · | Acquired | -97.8% (price as of 2026-10-06) |
| June 21, 2022 | JBIO | A | 12,500 | · | · | 12,500 Direct | · | Acquired | (price as of 2026-10-06) |
| May 24, 2022 | VERA | A | 9,925 | · | · | 9,925 Direct | · | Acquired | (price as of 2026-10-06) |
| Jan. 3, 2022 | JBIO | A | 7,240 | $6.56 | $47,494 | 7,240 Direct | · | Acquired | -94.0% (price as of 2026-10-06) |
| July 2, 2021 | JBIO | C | 10,565,238 | · | · | 0 Indirect | -100.00% | Disposed | (price as of 2026-10-06) |
| July 2, 2021 | JBIO | P | 357,142 | $14.00 | $4,999,988 | 3,758,686 Indirect | +10.50% | Acquired | -97.2% (price as of 2026-10-06) |
| July 2, 2021 | JBIO | C | 3,401,544 | · | · | 3,401,544 Indirect | · | Acquired | (price as of 2026-10-06) |
| July 1, 2021 | JBIO | A | 2,467 | $11.15 | $27,507 | 2,467 Direct | · | Acquired | -96.5% (price as of 2026-10-06) |
| June 29, 2021 | JBIO | A | 25,000 | · | · | 25,000 Direct | · | Acquired | (price as of 2026-10-06) |
| June 4, 2021 | JBIO | A | 8,082,190 | $1.89 | $15,275,339 | 10,565,238 Indirect | +325.49% | Acquired | -79.3% (price as of 2026-10-06) |
| May 18, 2021 | VERA | C | 2,187,504 | · | · | 0 Indirect | -100.00% | Disposed | (price as of 2026-10-06) |
| May 18, 2021 | VERA | P | 727,272 | $11.00 | $7,999,992 | 2,914,776 Indirect | +33.25% | Acquired | 168.8% (price as of 2026-10-06) |
| May 18, 2021 | VERA | C | 2,187,504 | · | · | 2,187,504 Indirect | · | Acquired | (price as of 2026-10-06) |
| May 13, 2021 | VERA | A | 9,925 | · | · | 9,925 Direct | · | Acquired | (price as of 2026-10-06) |
| Feb. 1, 2021 | JBIO | A | 1,164,213 | $1.89 | $2,200,363 | 2,483,048 Indirect | +88.28% | Acquired | -79.3% (price as of 2026-10-06) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 14, 2025 | VERA | Stock Option (right to buy) | Class A Common Stock | $21.19 | May 13, 2035 | 14,000 | Acquired |
| June 5, 2024 | JBIO | Stock Option (Right to Buy) | Common Stock | $18.90 | June 4, 2034 | 12,500 | Acquired |
| May 15, 2024 | VERA | Stock Option (right to buy) | Class A Common Stock | $42.69 | May 14, 2034 | 14,000 | Acquired |
| Jan. 2, 2024 | JBIO | Stock Option (Right to Buy) | Common Stock | $21.81 | Jan. 1, 2034 | 3,519 | Acquired |
| June 6, 2023 | JBIO | Stock Option (Right to Buy) | Common Stock | $16.30 | June 5, 2033 | 12,500 | Acquired |
| May 10, 2023 | VERA | Stock Option (right to buy) | Class A Common Stock | $7.70 | May 9, 2033 | 20,000 | Acquired |
| Jan. 3, 2023 | JBIO | Stock Option (Right to Buy) | Common Stock | $27.03 | Jan. 2, 2033 | 2,627 | Acquired |
| June 21, 2022 | JBIO | Stock Option (Right to Buy) | Common Stock | $12.26 | June 20, 2032 | 12,500 | Acquired |
| May 24, 2022 | VERA | Stock Option (right to buy) | Class A Common Stock | $16.14 | May 23, 2032 | 9,925 | Acquired |
| Jan. 3, 2022 | JBIO | Stock Option (Right to Buy) | Common Stock | $10.93 | Jan. 2, 2032 | 7,240 | Acquired |
| July 2, 2021 | JBIO | Series A Preferred Stock | Common Stock | · | · | 10,565,238 | Disposed |
| July 1, 2021 | JBIO | Stock Option (Right to Buy) | Common Stock | $19.41 | June 30, 2031 | 2,467 | Acquired |
| June 29, 2021 | JBIO | Stock Option (Right to Buy) | Common Stock | $14.00 | June 28, 2031 | 25,000 | Acquired |
| June 4, 2021 | JBIO | Series A Preferred Stock | Common Stock | · | · | 8,082,190 | Acquired |
| May 18, 2021 | VERA | Series C Preferred Stock | Class A Common Stock | · | · | 2,187,504 | Disposed |
| May 13, 2021 | VERA | Stock Option (right to buy) | Class A Common Stock | $11.00 | May 12, 2031 | 9,925 | Acquired |
| Feb. 1, 2021 | JBIO | Series A Preferred Stock | Common Stock | · | · | 1,164,213 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.